Sean McCutcheon
Stock Analyst at Raymond James
(0.24)
# 3,254
Out of 4,479 analysts
4
Total ratings
33.33%
Success rate
-20.12%
Average return
Main Sectors:
Top Industries:
3 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XNCR Xencor | Maintains: Strong Buy | $58 → $40 | $19.02 | +110.30% | 1 | Jun 14, 2024 | |
| CYTK Cytokinetics | Maintains: Outperform | $92 → $70 | $54.70 | +27.97% | 2 | May 23, 2024 | |
| LEGN Legend Biotech | Initiates: Outperform | $86 | $46.02 | +86.88% | 1 | Mar 13, 2024 |
Xencor
Jun 14, 2024
Maintains: Strong Buy
Price Target: $58 → $40
Current: $19.02
Upside: +110.30%
Cytokinetics
May 23, 2024
Maintains: Outperform
Price Target: $92 → $70
Current: $54.70
Upside: +27.97%
Legend Biotech
Mar 13, 2024
Initiates: Outperform
Price Target: $86
Current: $46.02
Upside: +86.88%